A detailed history of Goldman Sachs Group Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 69,410 shares of THRD stock, worth $885,671. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,410
Previous 36,312 91.15%
Holding current value
$885,671
Previous $472,000 99.15%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.86 - $15.0 $359,444 - $496,470
33,098 Added 91.15%
69,410 $940,000
Q2 2024

Aug 13, 2024

SELL
$8.74 - $15.54 $275,930 - $490,613
-31,571 Reduced 46.51%
36,312 $472,000
Q1 2024

May 15, 2024

BUY
$8.6 - $11.24 $444,284 - $580,669
51,661 Added 318.46%
67,883 $640,000
Q4 2023

Feb 13, 2024

BUY
$5.97 - $11.47 $96,845 - $186,066
16,222 New
16,222 $177,000
Q2 2023

May 14, 2024

SELL
$4.18 - $5.33 $159,007 - $202,753
-38,040 Reduced 69.8%
16,460 $79,000
Q2 2023

Aug 14, 2023

BUY
$4.18 - $5.33 $68,802 - $87,731
16,460 New
16,460 $79,000
Q3 2022

May 14, 2024

BUY
$16.75 - $19.93 $641,156 - $762,880
38,278 Added 235.96%
54,500 $1.03 Million
Q3 2022

Nov 10, 2022

BUY
$16.75 - $19.93 $912,875 - $1.09 Million
54,500 New
54,500 $0

Others Institutions Holding THRD

About Third Harmonic Bio, Inc.


  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $515M
More about THRD
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.